Security For Network-Connected Vehicles and Other Network-Connected Processing Environments
    1.
    发明申请
    Security For Network-Connected Vehicles and Other Network-Connected Processing Environments 失效
    网络连接车辆和其他网络连接处理环境的安全

    公开(公告)号:US20080092227A1

    公开(公告)日:2008-04-17

    申请号:US11950812

    申请日:2007-12-05

    IPC分类号: G06F21/00

    摘要: A method and apparatus provide security for a network-connected vehicle (or other networked environment) in which a predefined set of permitted operations relating to protected resources can be initiated remotely from elsewhere in the network, while security is maintained for the protected resources (for example, an engine performance optimisation control unit or air conditioning control unit within a vehicle) by preventing remote initiation of any other operations on a data processing unit which is connected to the protected resources. One of a pair of gateway components runs on each of two data processing units within the vehicle (or other environment), the first processing unit being connected to the vehicle's device control units and the second processing unit being connected to the external network. The gateway components control the types of communications which can be passed from the network-connected side to the first processing unit such that only permitted operations can be requested and no unauthorised operations can be initiated remotely.

    摘要翻译: 一种方法和装置为网络连接的车辆(或其他网络化环境)提供安全性,其中与受保护的资源相关的预定义的一组允许的操作可以从网络中的其他地方远程启动,同时为受保护的资源保持安全性(对于 例如,车辆内的发动机性能优化控制单元或空调控制单元),通过防止在连接到受保护资源的数据处理单元上的任何其他操作的远程启动。 一对网关组件中的一个在车辆(或其他环境)内的两个数据处理单元中的每一个上运行,第一处理单元连接到车辆设备控制单元,第二处理单元连接到外部网络。 网关组件控制可以从网络连接侧传递到第一处理单元的通信类型,使得只能请求允许的操作,并且可以远程地发起未经授权的操作。

    Pharmaceutical formulation
    3.
    发明授权
    Pharmaceutical formulation 有权
    药物制剂

    公开(公告)号:US09339478B2

    公开(公告)日:2016-05-17

    申请号:US13021240

    申请日:2011-02-04

    摘要: A pharmaceutical composition in the form of a tablet including a first portion and a second portion, wherein said first portion includes guaifenesin having an immediate release profile and a second drug having a sustained release profile, and wherein the second portion includes guaifenesin having a sustained release profile. The second drug can be in the form of a drug-resin complex. The second drug can be either an anti-tussive or a decongestant. The drug-resin complex includes a drug complexed to an ion exchange resin. The ion exchange resin can be a polystyrene sulfonate resin, polacrilex resin, polacrilin potassium, cholestyramine resin, or a colestyramine resin. The drug-resin complex can be provided with a coating, the coating thickness being selected to obtain the desired release profile. The drug-resin complex can be provided with a coating level of from 5% to 50%. The coating level can be from 10% to 35%.

    摘要翻译: 一种片剂形式的药物组合物,包括第一部分和第二部分,其中所述第一部分包括立即释放曲线的愈创甘油醚和具有持续释放曲线的第二药物,其中第二部分包括持久释放的愈创甘油醚 个人资料 第二种药物可以是药物 - 树脂复合物的形式。 第二种药物可以是抗咳嗽或减充血剂。 药物 - 树脂复合物包括与离子交换树脂络合的药物。 离子交换树脂可以是聚苯乙烯磺酸酯树脂,聚乙烯树脂,聚丙烯酸钾,考来烯胺树脂或考来烯胺树脂。 药物 - 树脂复合物可以设置有涂层,选择涂层厚度以获得所需的释放曲线。 药物 - 树脂复合物可以具有5%至50%的包衣水平。 涂层水平可以为10%至35%。